Medical Countermeasures COVID Moonshot Consortium Announces Crowd-Sourced Small Molecule DiscoveryNovember 11, 2023
Virginia Tech Lab Selected for National Partnership to Fight Emerging Diseases Biosecurity November 14, 2023
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 NanoViricides, Inc. today reported that its broad-spectrum antiviral drug candidate, NV-387 was highly effective in an animal model that is used…
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and SmallpoxNovember 14, 2023
Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 BoosterSeptember 20, 2023
U.S. Army Laboratory Technicians Train with Romanian Troops at Bucharest Biological Research FacilitySeptember 1, 2023
Medical Countermeasures Call for Experts: Smallpox Medical CountermeasuresGlobal Biodefense StaffOctober 28, 2023
APHIS Announces Funding for Tribes to Support Animal Disease Preparedness and Response Contracts + Grants October 24, 2023
USDA APHIS Announces Partnership to Improve Early Detection of Emerging Animal Diseases Biosecurity October 17, 2023
Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease Biosecurity September 24, 2023
With Mississippi Declared Endemic Area for Melioidosis Pathogen – Public Health Needs Support to Respond
Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus
Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic PathogensSeptember 24, 2023
